New Delhi, July 25 (IANS) The phased tariff plan announced by the US administration on imported generic medicines is expected to have a limited impact on the credit profiles of Indian pharmaceutical companies over the next two financial years, a report said on Saturday.As per analysis of Infomerics Ratings, the US — one of the largest markets for Indian drugmakers — imported pharmaceutical products worth $9.47 billion from India in FY26, accounting for nearly 30 per cent of the country’s overa…
Latest Rohit Inamdar News & Updates
New Delhi, March 11 (IANS) The Sustainable Harnessing and Advancement of Nuclear Energy for Transforming India (SHANTI) Bill, 2025 is a structural step toward strengthening India’s nuclear power ecosystem which will improve project execution, a report said on Wednesday.Infomerics Ratings described the bill as “structural long-term positive” for the Indian power sector for addressing long-standing deterrents to nuclear capacity addition, particularly liability and participation constraints.The …